FBXO22 and glioblastoma: In the present study, we reported for the first time that FBXO22-mediated increases in HIF-1α and VEGFA expression can promote GBM cell viability and angiogenesis by binding and degrading VHL, revealing a new mechanism by which FBXO22 promotes GBM malignant progression.